Marine n-3 Fatty Acids and the Risk of Peripheral Arterial Disease

Journal of the American College of Cardiology

Volumn 72, Issue 14, 2018, Pages 1576-1584

  Lasota, Anne N ^a,b   Grønholdt, Marie Louise M ^b   Bork, Christian S ^a   Lundbye Christensen, Søren ^a   Overvad, Kim ^a,c   Schmidt, Erik B ^a,b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

adipose tissue; case cohort study; docosahexaenoic acid; eicosapentaenoic acid; marine n 3 polyunsaturated fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; BIOLOGICAL MARKER;

ADIPOSE TISSUE; ADULT; ARTICLE; BIOPSY; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GAS CHROMATOGRAPHY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RISK FACTOR; TISSUE LEVEL; VALIDATION PROCESS; DENMARK; METABOLISM;

ADIPOSE TISSUE; BIOMARKERS; CHROMATOGRAPHY, GAS; COHORT STUDIES; DENMARK; FATTY ACIDS, OMEGA-3; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE;

EID: 85053472777     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2018.07.045     Document Type: Article

References (29)

1. Criqui, M.H., Aboyans, V., Epidemiology of peripheral artery disease. Circ Res 116 (2015), 1509–1526.
2. Fowkes, F.G.R., Rudan, D., Rudan, I., et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382 (2013), 1329–1340.
3. Gammelmark, A., Nielsen, M.S., Bork, C.S., et al. Adipose tissue content of marine n-3 polyunsaturated fatty acids is inversely associated with myocardial infarction. J Am Coll Cardiol 67 (2016), 1008–1009.
4. Joensen, A.M., Overvad, K., Dethlefsen, C., et al. Marine n-3 polyunsaturated fatty acids in adipose tissue and the risk of acute coronary syndrome. Circulation 124 (2011), 1232–1238.
5. Saber, H., Yakoob, M.Y., Shi, P., et al. Omega-3 fatty acids and incident ischemic stroke and its atherothrombotic and cardioembolic subtypes in 3 US cohorts. Stroke 48 (2017), 2678–2685.
6. Enns, J.E., Yeganeh, A., Zarychanski, R., et al. The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis. BMC Cardiovasc Disord, 14, 2014, 70.
7. Campbell, A., Price, J., Hiatt, W.R., Omega-3 fatty acids for intermittent claudication. Cochrane Database Syst Rev, 7, 2013, CD003833.
8. Hodson, L., Skeaff, C.M., Fielding, B.A., Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 47 (2008), 348–380.
9. Witt, P.M., Christensen, J.H., Ewertz, M., Aardestrup, I.V., Schmidt, E.B., The incorporation of marine n-3 PUFA int platelets and adipose tissue in pre- and postmenopausal women: a randomised, double-blind, placebo-controlled trial. Br J Nutr 104 (2010), 318–325.
10. Beynen, A.C., Katan, M.B., Rapid sampling and long-term storage of subcutaneous adipose-tissue biopsies for determination of fatty acid composition. Am J Clin Nutr 42 (1985), 317–322.
11. Arab, L., Akbar, J., Biomarkers and the measurement of fatty acids. Public Health Nutr 5 (2002), 865–871.
12. Tjønneland, A., Overvad, K., Thorling, E., Ewertz, M., Adipose tissue fatty acids as biomarkers of dietary exposure in Danish men and women. Am J Clin Nutr 57 (1993), 629–633.
13. Tjønneland, A., Olsen, A., Boll, K., et al. Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 35 (2007), 432–441.
14. Lasota, A.N., Overvad, K., Eriksen, H.H., Tjønneland, A., Schmidt, E.B., Grønholdt, M.-L.M., Validity of peripheral arterial disease diagnoses in the Danish National Patient Registry. Eur J Vasc Endovasc Surg 53 (2017), 679–685.
15. Kalbfleisch, J.D., Lawless, J.F., Likelihood analysis of multi-state models for disease incidence and mortality. Stat Med 7 (1988), 149–160.
16. Schoenfeld, D., Partial residuals for the proportional hazards regression model. Biometrika 69 (1982), 239–241.
17. Saary, M.J., Radar plots: a useful way for presenting multivariate health care data. J Clin Epidemiol 61 (2008), 311–317.
18. Willett, W.C., Howe, G.R., Kushi, L.H., Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65 (1997), 1220S–1228S.
19. Norgren, L., Hiatt, W.R., Dormandy, J.A., Nehler, M.R., Harris, K.A., Fowkes, F.G.R., Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45 (2007), S5–S67.
20. Baylin, A., Campos, H., The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol 17 (2006), 22–27.
21. Ogilvie, R.P., Lutsey, P.L., Heiss, G., Folsom, A.R., Steffen, L.M., Dietary intake and peripheral arterial disease incidence in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 105 (2017), 651–659.
22. Grenon, S.M., Hughes-Fulford, M., Rapp, J., Conte, M.S., Polyunsaturated fatty acids and peripheral artery disease. Vasc Med 17 (2012), 51–63.
23. Burdge, G.C., Calder, P.C., Dietary α-linolenic acid and health-related outcomes: a metabolic perspective. Nutr Res Rev, 19, 2006, 26.
24. De Caterina, R., n–3 fatty acids in cardiovascular disease. N Engl J Med 364 (2011), 2439–2450.
25. Freeman, A.M., Morris, P.B., Barnard, N., et al. Trending cardiovascular nutrition controversies. J Am Coll Cardiol 69 (2017), 1172–1187.
26. Thies, F., Garry, J., Yaqoob, P., et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361 (2003), 477–485.
27. Howe, P., Buckley, J., Meyer, B., Long-chain omega-3 fatty acids in red meat. Nutr Diet 64 Suppl 4 (2007), S135–S139.
28. Skulas-Ray, A., Flock, M., Richter, C., Harris, W., West, S., Kris-Etherton, P., Red blood cell docosapentaenoic acid (DPA n-3) is inversely associated with triglycerides and C-reactive protein (CRP) in healthy adults and dose-dependently increases following n-3 fatty acid supplementation. Nutrients 7 (2015), 6390–6404.
29. Sun, Q., Ma, J., Campos, H., et al. Blood concentrations of individual long-chain n–3 fatty acids and risk of nonfatal myocardial infarction. Am J Clin Nutr 88 (2008), 216–223.